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TRANSCRIPTOME PROFILING OF CLEFT PALATE IN TGF-3 KNOCKOUT MICE 
ALLELES: RNA-SEQ ANALYSIS OF TGF-3 MICE 
Kelsey M. White, D.D.S., M.S. 
University of Nebraska, 2017 
 
Background: Orofacial clefts are the most common craniofacial birth defect with a complex, 
combinatorial etiology.  Tgf-3 regulates palatal fusion in mice; Tgf-3 knockout mice have cleft 
palate (CP) lacking other major deformities.  The genes downstream of Tgf-3 during palatogenesis 
remain largely unexplored.  Our objective was to analyze the global transcriptome changes and 
their contribution to CP and identify novel Tgf-3 associated genes involved in formation of CP.  
We used RNA-sequencing to analyze and compare the whole transcriptome of Tgf-3 alleles during 
palatal growth and fusion in mice. 
Results: The whole transcriptome analysis of Tgf-3 mice (C57BL/6) alleles revealed over 6000 
significantly differentially expressed genes from 14.5 and 16.5 days post coitum (dpc), in wild type 
(WT) and homozygous (HM) genotypes.  A majority of differentially expressed genes were 
upregulated (WT=2421; HM=3153) compared to downregulated (WT=1694; HM= 2151) over 
time.  With a 2.0 fold-change cut-off, downregulated genes decreased dramatically (WT=134, 
HM=191) compared to upregulated genes (WT=1675; HM=1936).  Comparatively, gene 
expression differences between WT and HM were minimal.  Using Ingenuity® Pathway Analysis 
(IPA) we identified genes which may function as primary contributors to the development of CP. 
Conclusions: Using RNA-seq analysis, we provided a global analysis of transcriptome changes 
between and within WT and HM in the Tgf-3 mouse model system at critical stages of palate 
development.  We identified genes that likely play key regulatory roles during palatogenesis 
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CHAPTER 1: REVIEW OF LITERATURE 
1.1 Introduction 
 
One in every thirty-three babies born in the United States has a birth defect; birth defects are a 
leading cause of infant mortality and lifelong disability.  Orofacial clefts are the most commonly 
treated craniofacial defect in the pediatric hospital setting with a lifetime cost estimated at 
approximately $100,000 (Jugessur et al., 2009).  According to national prevalence estimates, cleft 
lip with or without cleft palate is the second most common defect with a prevalence ranging from 
1/500 to 1/2500 based on geographic origin, racial and ethnic background, and socioeconomic 
status (Schutte & Murray, 1999, Parker et al., 2010).   Both the financial burden and prevalence of 
orofacial clefts warrant investigation into the underlying cause of the deformity with the goal of 
improving prevention, treatment, and prognosis for affected individuals. 
Orofacial clefts are a congenital disruption to facial structure.  In addition to the notable 
facial deformity, orofacial clefts cause difficulty feeding, speaking, hearing, and socially interacting 
requiring highly-coordinated, interdisciplinary care throughout life.  Treatment including surgery, 
dental treatment, speech therapy and psychosocial intervention start as early as ten weeks of age 
and continue through adulthood (Dixon et al., 2011).  The causes of orofacial clefts are a complex 
combination of genetic and environmental factors lending to difficulty in fully understanding the 
role of genes and the environment in this embryological disturbance (Schutte & Murray, 1999).  
Previous research has identified several genes that play significant roles in palatogenesis, such as 
TGF-3, and are likely implicated in cleft palate formation (Dixon et al., 2011). 
Members of the TGF family play crucial roles in facial development as demonstrated in 
several studies.  The Tgf-3 knockout mouse model results in the phenotype of cleft palate.  In 
chickens where the palate is normally cleft, exogenous Tgf-3 has been shown to induce palate 





3 are associated with cleft palate in humans (Zhu et al., 2012b).  Research continues to show that 
TGF-3 is fundamentally important in successful palate development; however we have yet to 
completely explore the biological mechanisms downstream of TGF-3.  A complete gene analysis 
of Tgf-3 mouse alleles will allow us to elucidate genes under control of TGF-3 in proper palate 
formation and those in the knockout model implicated in cleft formation.   
1.2 Orofacial Clefts 
 
Reported prevalence of orofacial clefts varies worldwide; orofacial clefts occur in 
approximately one in 700 live births.  Prevalence in gender and sidedness also differ with 2:1 male 
to female ratio in cleft lip, 1:2 male to female ratio in cleft palate, and 2:1 ratio of left to right sided 
clefts (Dixon et al., 2011).  Incidence is greatest in American Indians followed by Asians, 
Europeans and least in African Americans (Panamonta et al., 2015).   
Orofacial clefts have varying degrees of phenotypic presentation as shown in Figure 1.  Cleft 
lip can present with or without cleft palate (CL/P) or the cleft can be confined to the palate only 
(CPO) (Dixon et al., 2011).  Orofacial clefts can occur as part of a syndrome—approximately 30% 
of CL/P and 50% of CPO cases are syndromic and a result of chromosomal anomalies, Mendelian 
syndromes, or teratogenic exposure.  A majority of orofacial clefts are non-syndromic, having no 
other associated anomalies.  These categorizations lend to four specific groups of clefts: syndromic 
CL/P, syndromic CPO, non-syndromic CL/P, and non-syndromic CPO (Schutte & Murray, 1999).  
Accurate identification of phenotype is crucial in understanding underlying genetic etiology in non-
syndromic CL/P and CPO.  Various presentations clinically reflect genetic heterogeneity.  New 
studies suggest that phenotypic presentation is a more complex spectrum including minor structural 
variants such as lip pits, dental anomalies, defects of the orbicularis oris muscle, and speech or 





phenotyping could lend to more evidence in twin studies and familial clustering studies (Dixon et 
al., 2011).   
The complex, heterogeneous etiology of orofacial clefts involves several environmental 
teratogens and a multitude of genes.  Noted teratogens, such as smoking, increase risk of orofacial 
clefts by as much as 6% (Beaty et al., 2006).  Additionally, certain drugs, maternal alcohol use, and 
pesticides have the ability to disrupt normal facial development during embryogenesis resulting in 
a cleft.  Epidemiological studies of indigent populations suggest that both socioeconomic status 
(SES) and maternal nutrition are risk factors of orofacial clefts; the prevalence of orofacial clefts is 
higher in populations of lower SES.  In these populations, it is difficult to separate the risk 
contribution of SES and maternal nutrition; however, it is suggested that environmental factors are 
responsible for as much as one-third of orofacial cleft cases in indigent populations (Schutte & 
Murray, 1999).  While the environment has notable effects on palate development, the genetic 
component of cleft palate (CP) is being aggressively studied. 
Genetic perturbations have been associated with orofacial clefting through family, twin, and 
epidemiologic studies (Spritz, 2001).  According to a population study in Norway, first-degree 
relatives (parents, full siblings, and offspring) have a 32 time higher risk with CL/P and 56 time 
higher risk with CPO.  Relatives of patients with non-syndromic CL/P have an increased risk of 
recurrence; with the decreasing degree of relationship, the risk also decreases (Spritz, 2001).  
However, a family with numerous individuals affected is rare, suggesting that the defect is likely a 
result of a combination of multiple genes with additive risk, as well as its previously suggested 
environmental contribution.  Similarly, studies involving monozygotic twins confirm that the 
etiology of orofacial clefts is a result of both genetic and environmental components.  Concordance 
of monozygotic twins, 47%, was significantly greater than that of dizygotic, 8%--a purely genetic 
epidemiology would result in 100% concordance in monozygotic twins (Beaty et al., 2006).  





One major modality of research focuses on the genetic components of syndromic forms of CP.  
Even though CP lacks a true Mendelian inheritance pattern, studies rely on exploration of 
syndromes including cleft palate since underlying mechanisms of cleft formation may be similar 
(Iwata et al., 2011).  X-linked cleft palate and Van der Woude syndrome are two examples of 
syndromes with similar phenotypic presentation to orofacial clefts (Schutte & Murray, 1999).  
Further assessment of the etiology of orofacial clefts will improve our understanding of the facial 
deformity and include genetic and environmental risk assessment applicable for genetic counseling 
and prevention (Dixon et al., 2011).  Genetic linkage and association studies are conducted to 
identify loci and genes responsible for orofacial clefts.  Due to low numbers of families and high 
heterogeneity, loci have not been consistently identified among studies.  Human  genes with 
identified association include TGF-3 (Murray, 2002).  The TGF isoforms have been shown to 
be intricately involved in palate fusion warranting a thorough investigation of their role and 













Figure 1. A) Illustrations of different types of orofacial clefts; a and e show unilateral and 
bilateral clefts of the soft palate; b, c and d show degrees of unilateral cleft lip and palate; f, g, 








Transforming growth factor-3 (TGF-3) belongs to the  growth factor superfamily 
consisting of more than 30 ligand proteins, signaling through Smads or MAPKs (Zhu et al., 2012b, 
Nawshad et al., 2004).  This gene family is involved in biological activities that control cell 
proliferation, migration and differentiation; regulate extracellular matrix deposition; and promote 
epithelial-mesenchymal transformation (EMT).  The three isoforms—1, 2, 3—are highly 
conserved between species with 71-76% sequence identity and have distinct spatial and temporal 
expression (Zhu et al., 2012b).  Further, phenotypes resulting from knockouts of each TGF 
isoform are distinct and cannot be compensated by other family members.  Mutations of Tgf-1 in 
mice do not survive beyond 11 dpc and cannot be evaluated for palatal involvement; Tgf-2 
knockout mice have defects of the maxilla and mandible with only 23% having cleft palate; and 
Tgf-3 knockout mice show cleft palate only with 100% penetrance (Nawshad et al., 2004). 
The TGF isoforms have shown to be spatially and temporally distinct.  As shown in mouse 
palate development, Tgf-1 is involved in both epithelial and mesenchymal tissues, Tgf-2 is 
mainly in mesenchymal tissues, and Tgf-3 is expressed in medial edge epithelium (Ichikawa et 
al., 2006).  Further, Tgf-3 appears to be solely responsible for fusion of palatal shelves regulating 
periderm sloughing and EMT of the medial edge epithelium (Nawshad et al., 2004, Hu et al., 
2015a).   
 
1.4 TGF-3 Signaling and Downstream Molecules 
Well-coordinated processes including cell migration, apoptosis, cell morphology, cell cycle 
progression, growth, and proliferation are essential for proper palate formation.  Palatogenesis 
occurs in four main steps: vertical shelf growth, elevation, adhesion, and fusion (Zhu et al., 2012b).  





of Tgf-3 activity resulted in failure of palatal fusion of organ cultures.   Tgf-3 has also been 
shown to rescue palatal fusion in Tgf-3 knockout mice (Meng et al., 2009).   
The TGF isoforms are uniquely able to signal via multiple pathways including SMAD, G 
protein/MAPK, and PI3 kinase with divergent signaling outcomes (Nawshad et al., 2005).  In the 
SMAD-dependent pathway, illustrated in Figure 2, the TGF ligands signal through 
serine/threonine kinase receptor complexes TGF type I receptor (TrI) and TGF type II receptor 
(TrII).  TGF ligand first binds to TrI; TrI becomes phosphorylated and active with the binding 
of the ligand (Jugessur et al., 2009).  The TrII is recruited to the complex forming a 
heterotetrameric signaling complex.  This complex is internalized into an early endosome and 
receptors are recycled back to the membrane.  In the early endosome, protein SMAD anchor for 
receptor activation (SARA) modulates the interaction of SMAD2/3 to TGF receptors forming 
TGFIr/SARA/SMAD2 or 3 complex (Nawshad et al., 2005).  Phosphorylation of SMAD2 and/or 
SMAD3 allows association with SMAD4; SMAD4 ushers the complex into the nucleus for 
transcriptional activation or repression of TGF target genes (Cui et al., 2003).  For example, target 
gene lymphoid-enhancing factor 1 (LEF1), has been shown to upregulate genes involved in EMT, 
an essential component of palatogenesis (Nawshad & Hay, 2003).  Both in vivo and in vitro 
experiments confirm TGF-mediated SMAD signaling is the major pathway for EMT required for 








Figure 2. Illustration of Smad-dependent TGF signaling pathway during palatal EMT.  TGF- 
ligand bind TGF- receptors I and II at the cell surface.  After phosphorylation of TGFIr, 
receptors internalize with the ligand into a plasma membrane pit forming vesicles and early 
endosomes in the cytosol with phosphorylated receptors and ligand attached.  Protein SARA 
modulates cellular trafficking and transports cytoplasmic Smad2/3 to the TGF- receptors to form 
TGFIr/SARA/Smad2 or 3 complexes.  Smad2 or 3 is phosphorylated and with help of Smad4 






1.5 Craniofacial Development 
Craniofacial development is a complex process that begins at the fourth week in utero.  
Craniofacial development relies on migration of cranial neural crest (CNC) cells to guide the 
patterning of the face by populating the branchial arches (Chai & Maxson, 2006).  The timing and 
extent of migration is tightly controlled by highly conserved homeobox genes (Marazita & 
Mooney, 2004).  Neural crest cells migrate into the developing branchial arches and are the source 
of skeletal and connective tissue structures (Alappat et al., 2003). 
Development of the face, illustrated in Figure 3, results from harmonized growth and 
differentiation of five facial primordia—the medial frontonasal prominence, paired maxillary 
prominences, and paired mandibular prominences—surrounding the primitive oral cavity (Alappat 
et al., 2003).  Both the maxillary and mandibular prominences grow toward each other in the 
midline where they will fuse forming the upper jaw and lip and lower jaw and lip, respectively.  
The frontonasal process forms the forehead, nose, lip, philtrum and primary palate (Cordero et al., 
2011).  Within the frontonasal prominence, nasal placodes form from localized thickenings of the 
surface ectoderm eventually forming the nasal pits, lateral and medial nasal prominences (Alappat 
et al., 2003).  The maxillary prominences fuse with the lateral and medial nasal prominences 
bilaterally followed by the intermaxillary segment of the frontonasal process (Alappat et al., 2003).  
Failure of the maxillary prominences to fuse with the medial nasal prominence on one or both sides 
can result in a unilateral cleft lip or bilateral cleft lip, respectively (Alappat et al., 2003). 
Palatogenesis begins during week five and continues through week twelve forming the primary 
and secondary palates (Chai & Maxson, 2006, Lan et al., 2015).  The primary palate is anterior to 
the incisive foramen and consists of the philtrum, incisors, and a small portion of the hard palate.  
Located posterior to the incisive foramen, the secondary palate begins formation at week six of 





start as vertical extensions of the maxillary processes on either side of the tongue.  The developing 
lower jaw allows the tongue position to lower during the eighth week and the palatal shelves to 
elevate into a horizontal position.  The palatal shelves grow towards each other fusing with the 
primary palate anteriorly, nasal septum dorsally, and each other at the midline.   When the palatal 
shelves adhere in the midline, the periderm covering the medial edge epithelium (MEE) must be 
eliminated first to allow the epithelial cells to fuse forming the midline epithelial seam (MES) (Chai 
& Maxson, 2006, Lan et al., 2015).  Although the mechanism is yet to be fully elucidated, MES 
cells have three possible fates to produce a confluent palate: EMT, apoptotic cell death, or migration 
of MES cells to oral or nasal sides of the palate (Nawshad, 2008, Lan et al., 2015).  Any disruption 
of palatal shelf growth, elevation, or fusion can result in a CP (Lan et al., 2015).  Palatal clefts can 









Figure 3. Schematic diagram of development of the face and palate in humans; a) Developing 
frontonasal prominence, paired maxillary and mandibular processes with primitive oral cavity by 
the fourth week of embryogenesis; b) Formation of nasal pits leading to paired medial and lateral 
nasal processes by week five; c) Medial nasal processes and maxillary processes merged forming 
the upper lip and primary palate by the sixth week of embryogenesis; d) Palate formation 
beginning at week six as bilateral outgrowths from the maxillary processes on either side of the 






1.6 Mouse Model System 
Animal models have significantly improved our understanding of the genetic activity in 
palatogenesis.  Over 200 genetically mutated mice exhibit CP phenotype (Iwata et al., 2011).  
Palatogenesis is remarkably similar in humans and mice providing an ideal model system to assess 
the role of particular genes in orofacial deformity (Nawshad et al., 2004, Chai & Maxson, 2006).  
Several mouse strains with CP are available; Msx1, Tgf-3, and Ap-2 knockouts are three examples 
that result in cleft phenotype (Dixon et al., 2011, Schutte & Murray, 1999).  Several studies have 
confirmed the essential role of Tgf-3 in mouse palatogenesis; Tgf-3 mice have CP due to failed 
palatal shelf fusion with the absence of any other craniofacial deformity (Nawshad et al., 2004).   
The mouse is an ideal animal for the study of palatogenesis being both time- and cost-
effective with several offspring—a litter produces approximately 8 pups.  Mice have a short 
gestation period of 21-22 days with palatogenesis occurring from day 11-16dpc coordinating with 
human development weeks 6-12 in utero (Rabadan-Diehl & Nathanielsz, 2013).  Palate formation 
in mice, illustrated in Figure 4, begins at 11.0-11.5dpc.  Tgf-3 is detected throughout palate 
development in MEE.  After vertical growth is complete, palatal shelves elevate at 13.0-13.5dpc.  
Palatal shelves will grow towards each other and begin to contact at 14.0-14.5dpc.  Tgf-3 is found 
in the greatest quantity at the MEE during EMT and will persist until cells complete the 
transformation.  By 16.0-16.5dpc, palatal fusion has occurred (Nawshad et al., 2004).  The use of 
animal models, particularly mice, with CP has allowed the discovery of both cellular and molecular 








Figure 4. A-C: Camera lucida drawings of paraffin sections of the developing rodent palate; a) 
Between 13 and 14dpc palatal shelves move horizontally towards each other above the tongue 
during which the periderm layer sloughs off the epithelium along the medial palatal edge (p); b) 
Epithelial seams transform to mesenchyme to become confluent between 15 and 17dpc; c) Palate 
shelves fuse together with nasal septum (ns); D-G: Hematoxylin and eosin-stained sections of 
rodent palates fixed at different stages in palatogenesis in vitro; d) palatal shelves in contact with 
palatal seam (white arrow); e) seam disintegration; f) continued seam disintegration; g) palate 







Non-syndromic CL/P and CP have been extensively studied.  The causes of orofacial clefts are 
incredibly sensitive to environmental disturbances, making it difficult to identify and understand 
gene-gene and gene-environment interactions (Schutte & Murray, 1999).  The high prevalence of 
orofacial clefts and their devastating malformations continues to drive research to find precise 
genetic causes and targets for prevention.   
Several studies have confirmed that TGF-3 is paramount to palatal fusion in both primary 
cells and organ culture. While we know TGF-3 is a candidate gene for non-syndromic CP in 
humans, we still have yet to fully explore genes that are directly regulated by TGF-3 in both 
normal palate formation and CP (Ozturk et al., 2013).  In conclusion, the ability to provide an 
analysis of Tgf-3 and its downstream signaling effects during palatogenesis in a mouse model can 





CHAPTER 2: OBJECTIVE AND AIMS OF THE STUDY 
 
2.1 Objective and specific aims 
 The objective of this study was to analyze transcriptome changes and their contribution to 
the development of cleft palate at gestational ages 14.5dpc and 16.5dpc in Tgf-3 knockout mice 
alleles.  The specific aims of this project were to: 
 Using RNA-sequencing we will create a genome scale analysis of the palatal 
transcriptome of Tgf-3 WT and HM mice at critical stages of palatogenesis (14.5 and 
16.5dpc). 
 Our RNA sequencing data will show a comprehensive analysis of Tgf-3 signaling 
effects during palatogenesis and genes subsequently altered in mutants causing palatal 
cleft. 
 Our genome scale analysis of the palatal transcriptome will identify exact functional 
cellular changes that are active during palatogenesis and compromised in Tgf-3 HM 
palates.  
2.2 Hypothesis 
   We hypothesize that there will be a differential expression of novel genes between Tgf-3 
WT and HM mice at different time points critical to palate development (14.5 and 16.5dpc) 







CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Introduction 
 This chapter describes the materials and methods used to analyze the transcriptome 
changes of Tgf-3 mice using RNA-sequencing at critical stages in palatal development.  While 
substantial evidence shows the importance and role of TGF-3 in palatal fusion and its implication 
in CP, we do not know what cellular pathways are directly or indirectly regulated by TGF-3 during 
palatogenesis. 
 The purpose of this study is to enhance our knowledge of the role of TGF-3 in normal 
palatogenesis and in formation of a cleft by exploring the differentially expressed genes at 14.5 and 
16.5dpc in a mouse model.  Our particular interest is any gene up-regulated or down-regulated in 
the Tgf-3 WT versus HM alleles.  We then hope to define the involvement of dysregulated genes 
in the cellular mechanisms underlying palatogenesis improving our knowledge of downstream 
effects of TGF signaling.  Results from such analysis will identify new candidate genes that may 
aid in our attempt to fully elucidate the mechanism underlying this orofacial deformity. 
3.2 Animal Selection and Breeding 
 Tgf-3 heterozygous (+/-) C57BL/6J male and female mice were provided by Tom 
Doetschman (BIO5 Institute, University of Arizona, AZ).  This specific mouse strain, C57BL/6J, 
has an increased susceptibility to teratogen-induced CP, making this strain ideal.  Mice were kept 
in accredited animal facilities at the University of Nebraska Medical Center (UNMC) and all 
procedures were approved and in accordance with the Institutional Animal Care and Use 
Committee (#06-064) of UNMC. 
 To produce heterozygous offspring for mating, a replacement type targeting vector was 





pMC1neo vector.  E14-1ES cells were transfected with the targeting vector with correct targeting 
found in 5/250 neomycin-resistant clones analyzed by Southern blot analysis.  Genomic DNA was 
prepared and injected into C57BL/6 blastocysts and mated.  Heterozygous offspring were 
confirmed with Southern blot analysis.  To produce HM (-/-) Tgf-3 mice, heterozygous mice were 
bred.  Litters contained approximately 25% homozygous pups as expected from Mendelian 
inheritance ratio (Proetzel et al., 1995).   
3.3 Dissection and Collection of Palatal Shelves 
 In pregnant female mice, the morning the vaginal plug was pulled was considered 0.5dpc.  
Pregnant female mice were euthanized by CO2 asphyxiation at 14.5 and 16.5dpc.  Upon dissection, 
embryos were placed in Hank’s Balanced Salt Solution (SIGMA-Aldrich, St. Louis, MO) to 
stabilize the embryos.  The embryos were dissected in sterile conditions under the Nikon SMZ1000 
stereomicroscope system (Nikon, Tokyo, Japan); palatal shelves and tails were collected from 5-
10 embryos per pregnancy (Figure 5).  Palatal tissues were stored in Invitrogen TM RNAlaterTM 
Stabilization Reagent (Qiagen, Hilgen, Germany) to preserve the gene expression profile.  Samples 













Figure 5: Process of palatal shelf extraction. a) Sterile laboratory dissection conditions; b) 
Embryonic pups from E16.5 pregnant female mouse; c) Palatal cleft in E16.5 pup. 
 
  





3.4 Genotype Confirmation 
 Embryonic genotyping was confirmed using PCR followed by gel electrophoresis.  Tissue 
samples, embryonic tails, were isolated from embryos at 14.5 and 16.5dpc.  Genomic DNA was 
prepared using the Gentra Puregene Tissue Kit (Qiagen, Hilden, Germany).  DNA concentration 
was confirmed using the NanoDrop 2000c spectrophotometer (NanoDrop, Wilmington, DE).  Tgf-
3 genotyping primers were attached to individually labeled tissue samples as follows: 
TGF-3 Forward 5’ TGG GAG TCA TGG CTG TAA CT 3’ 
TGF-3 Reverse 5’ CAC TCA CAC TGG CAA GTA GT 3’ 
These primers amplified 1200bp and 400bp for HM and WT alleles, respectively shown in Figure 
6.  PCR conditions were one cycle of 95ºC for 1.5 minutes followed by 35 cycles of 95ºC for 30 
seconds, 57ºC for 50 seconds, 72ºC for 1.5 minutes, and ended with one cycle of 72ºC for 5 minutes.  
Fifteen mL of PCR product from each reaction was loaded onto 1% agarose gel.  Electrophoresis 
was run at a constant 100V, 400mA and 400W for 1 hour and evaluated with Kodak Gel Logic 100 

















3.5 RNA Extraction and Purification 
Total proteins were collected from previously stored palatal shelves of 14.5 and 16.5dpc 
pups.  RNA was extracted using PicoPureTM RNA Isolation Kit (ThermoFisher Scientific, San 
Francisco, CA).  Further purification was done use DNase Treament (Qiagen, Hilden, Germany) 
as described previously (LaGamba et al., 2005, Zhu et al., 2012a).  Purity and concentration were 
measured by ultraviolet spectroscopy using the Nano Drop 2000c spectrophotometer (NanoDrop, 
Wilmington, DE).   
3.6 Preparation of cDNA Library 
 RNA was sent to University of Nebraska Medical Center Bioinformatics and Systems 
Biology Core Facility.  Libraries were prepared using Illumina mRNA-Seq Sample Preparation Kit 
(Illumina, San Diego, CA) according to manufacturer instructions.  Poly(A)+ RNA was recovered 
from 1 µg of total RNA using two rounds of hybridization with oligo-dT-cated Sera-Mag magnetic 
beads.  The recovered poly(A)+ RNA was then chemically fragmented and next converted to cDNA 
using SuperScript II and random primers.  The second strand was synthesized using RNaseH and 
DNA Pol I.  The ends of cDNA were repaired using T4 DNA polymerase, T4 polynucleotide 
kinase, and Klenow DNA polymerase.  A single adenosine was added to the 3’ end using Klenow 
fragment (3’ to 5’ exo minus).  Adapters were attached to both ends of cDNA using T4 DNA ligase.  
RNA fragments were extracted from a 2% low range ultra agarose sizing gel and amplified by 15 
cycles of PCR using Phusion® DNA Polymerase (Thermo Fisher Scientific, San Francisco, CA).  
Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA) was used to validate libraries.  Libraries 
were diluted and applied to Illumina flow cell using the IlluminaCluster Station (Illumina, San 
Diego, CA) as previously described (Ozturk et al., 2013). 





 RNA-sequencing (RNA-seq) was conducted using Illumina HiSeq2000 (Illumina, San 
Diego, CA) for Tgf-3 (-/-)  HM and Tgf-3 (+/+) WT samples profiled at 14.5 and 16.5dpc.  RNA-
seq uses high-throughput sequencing technology providing the ability to investigate RNA content 
from sequencing of cDNA and the ability to measure transcript quantity in a single assay (Roberts 
et al., 2011, Trapnell et al., 2012).  RNA-seq allows the rapid, comprehensive discovery of novel 
genes for a reasonable cost; simply, RNA-seq quantifies how often each gene is represented in a 
sample (Marguerat & Bahler, 2010).  Two independent biological and technical replicates were 
assayed at each time point for each both HM and WT to evaluate reproducibility of samples and 
procedures resulting in eight (n =  2 x 2 x 2) samples for sequencing performed in 2x101bp paired-
end mode.  Raw reads were analyzed with FASTQC (v. 0.11.5) for quality control (Andrews, 2010).  
Overrepresented sequences, for example those containing adapter or primer sequences, remaining 
in the raw reads were assessed and subsequently removed using Timmomatic (v 0.36) in the 
palindrome mode based on default alignment detection and scoring parameters (Bolger et al., 
2014).  Trimmomatic was also used for low-quality base filtering.  Maximum information quality 
filtering was employed with a minimum average read quality threshold of 25.  Following technical 
sequence and low-quality base removal, reads that were shorter than 36bp were removed.  
Transcript quantification was done based on the GRCm38.p5 reference genome using Salmon (v. 
0.8.2) with default parameters (Patro et al., 2017).  Salmon uses sample-specific models such as 
correction for GC-content bias that improves the accuracy of transcription abundance estimates.  
We use Transcripts Per Million (TPM) in Salmon’s output as the relative abundance measure 
employed in our downstream analysis.   
3.8 Comparison of Differential Gene Expression 
 Differential gene expression is evaluated using software tool DESeq2.  This program 
allows the analysis of read counts per gene based on set parameters, such as required fold-change  





employs the Benjamini Hochberg procedure for multiple hypotheses testing correction (Benjamini 
& Hochberg, 1995).  When comparing the transcription abundance between two groups of samples, 
we used the adjusted p-value cut-off of 0.05 to define statistically significant differential 
expression.  RVennDiagram was used to generate highly-customizable, high-resolution Venn 
diagrams for each experimental group with a fold change (FC) of 2.0 or greater (Ozturk et al., 
2013).  This allows a visual grouping of dysregulated genes by distinct region to compare HM and 
WT at two different time points. 
Clustering of samples was done using the Unweighted Pair Group Method with Arithmetic-
mean method using Pearson’s correlation as the distance measure (Sneath, 1973).  The expression 
data matrix was row-normalized prior to the application of average linkage clustering.  The 
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7  (Huang da et al., 
2009) was used for functional analysis of the gene lists interrogating Biological Process (BP), 
Molecular function (MF), and Cellular Component (CC) Gene Ontology (GO) categories 
(Ashburner et al., 2000) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
(Kanehisa & Goto, 2000a).  Biologically relevant categories that are over-represented in the gene 
set and therefore may be of further interest were assessed using Expression Analysis Systematic 
Explorer (EASE) score in the DAVID tool.  The EASE score is the upper bound of the distribution 
of Jackknife iterative resampling of Fisher exact probabilities with Bonferroni multiple testing 
correction.  Categories containing low numbers of genes are under-weighted so that the EASE score 
is more robust than the Fisher exact test.  The EASE score is a significance level with smaller EASE 
scores indicating increasing confidence in over-representation.  We selected GO categories that 
have EASE scores of 0.05 or lower as significantly over-represented. 
3.9 Biological Evaluation and Pathway Analysis  
 Differentially expressed genes between HM and WT were further analyzed using 





uploading data into IPA, a statistical analysis of RNA-seq data was performed.  For a gene to be 
considered differentially expressed, the adjusted p-value must be less than or equal to 0.05.   
Resulting RNA-Seq data Entrez IDs and fragments per kilobase per million mapped (FPKM) values 
were entered into IPA.  IPA is based on the manual curation of scientific literature to identify 
pathways, networks, and functional categories that are significantly represented in the input gene 
list.   
3.10 Confirmation of Dysregulated Genes with Real-Time PCR 
  To confirm dysregulated genes between WT and HM samples, quantitative real-time PCR 
(qPCR) was performed.  Palatal tissues were extracted from embryos at 14.5 and 16.5dpc and RNA 
extraction was conducted as previously described using PicoPureTM RNA Isolation Kit 
(ThermoFisher Scientific, San Francisco, CA) with DNase Treatment (Qiagen, Hilden, Germany) 
used to extract high-quality RNA consistently from very few cells (Zhu et al., 2012a, LaGamba et 
al., 2005).  RNA was converted to cDNA using SuperscriptTM IV VILOTM Master Mix 
(ThermoFisher Scientific, San Francisco, CA) providing a highly efficient and thermostable reverse 
transcriptase allowing significant cDNA yield at high temperatures in less time. An additional pre-
amplification step was conducted using TaqManTM PreAmp Master Mix (ThermoFisher Scientific, 
San Francisco, CA) with a custom pre-amplification pool of 32 selected genes of interest to amplify 
small amounts of cDNA without introducing amplification bias—specifically for small, precious 
mRNA samples—allowing more qPCR reactions.  Samples underwent 14 preamplification cycles 
were with thermal cycling conditions of 95C for 15 seconds and 60C for 4 minutes followed by 
immediate placement on ice.  Next, samples underwent 1:20 dilution diluted with TE buffer.  
Finally, samples were placed on 96-well custom array plates in technical triplicate and qPCR 
executed with TaqMan Fast Advanced Master Mix (ThermoFisher Scientific, San Francisco, CA) 
reagents.  PCR conditions were 40 cycles at 95C for 15 seconds and 60C for 1 minute. 





Technical repeat's normalized gene-specific CTCt value were subtracted from the 
housekeeping gene CtCt value. Then, data were analyzed using analysis of variance (ANOVA) on 
the repeat-normalized CtCt values, including the control group and translate effects estimated 
from the ANOVA onto the multiplicative scale. The values of tested 29 genes were normalized by 
adjusting for the concentration of abundant known house-keeping genes, like 18SrRNA, GAPDH 
and β-actin, and the Ct values of naive/vehicle group. PCR assays detecting the reference genes, 
18SrRNA, GAPDH or β-actin calculated alongside those for the gene of interest and the resulting 
dataset were analyzed. 18SrRNA, GAPDH, and β-actin are constitutively expressed and were 








CHAPTER 4: RESULTS 
4.1 RNA Sequencing Quality Analysis 
 The bioinformatics analysis of RNA-Sequencing showed raw RNAseq average read counts 
of 65.5 million paired-end reads (130.1 million total reads) per sample for the eight sample profiles 
(Figure 7a).  Average read-length started as 101 base pairs (bp) in raw reads, subsequently reduced 
to an average of 95.86bp following trimming and filtering (Figure 7b).  Overall average read quality 
score increased from 35.84 to 36.79 and the percentage of high quality bases—bases with a quality 
score greater than 20—per sample increased from 96.28% to 99.20% following trimming and 
filtering (Figure 7c and d).  Both the total number of reads and the average read length parameters 










































































4.2 RNA Sequencing Transcript Quantification 
 RNA-seq analysis generated expression data for 103,215 transcripts.  The transcripts with 
a TPM values less than 1.0 in all eight samples (WT14.5a, WT14.5b, WT16.5a, WT16.5b, 
HM14.5a, HM 14.5b, HM16.5a, HM16.5b) were eliminated from downstream analysis leaving 
52,475 transcripts.  Hierarchical clustering of all transcripts reveals that the samples are clearly 
separated by time with little effect of genotype warranting a need for supervised analysis methods 
to identify the differences in gene expression due to genotypic variance (Figure 8).  Further, the 
close proximity of branching at 14.5dpc in HM and WT compared to a more distant relationship at 
16.5dpc indicates that the samples are more similar at 14.5dpc with growing disparity over time.  












Figure 8: Hierarchical clustering of all the samples using all 52,475 transcripts with TPM>1 in at 






4.3 Differential Expression Analysis 
 Differential expression analysis showed a significant temporal difference in gene 
expression between samples; there were over 4115 significantly differentially expressed genes 
(SDEG) between 14.5 and 16.5dpc in WT samples and 5304 SDEGs between 14.5 and 16.5dpc in 
HM samples (Table 1).  From our transcriptome analysis, a majority of differentially expressed 
genes were upregulated (WT = 2421; HM = 3153) compared to downregulated (WT = 1694; HM 
= 2151) from 14.5 to 16.5dpc demonstrating that transcriptional induction overshadows 
transcriptional silencing between these time points.  A fold-change (FC) cut-off of 2.0 was applied 
to further define significant differential expression; downregulated differentially expressed genes 
decreased dramatically (WT=134, HM=191) compared to differentially expressed upregulated 
genes (WT=1675, HM=1936) again emphasizing the difference in upregulated versus 
downregulated genes.  Venn diagrams were created to illustrate the number of differentially 
expressed genes dysregulated from 14.5 to 16.5dpc in WT and HM (FC>2.0) (Figure 9a).  By 
comparison, the difference in gene expression between genotypes at the same time point was 
minimal (HM14.5 vs. WT 14.5 = 13; HM16.5 vs. WT16.5 = 38).  Again following trend, the 
genotype differences at 14.5dpc are minimal with no gene dysregulated with a FC>2.0 and a greater 
difference between genotypes at 16.5dpc and 13 genes dysregulated with FC>2.0.  With the 
difference in genotype minimal, we defined the effects of Tgf-3 knockout by comparing the 
temporal gene expression of WT and HM.  Genes significantly dysregulated within each genotype 
were termed “WT Specific” (WS, 479+72) and “HM Specific” (HS, 690+129) as depicted in Figure 
9a. 
Further analysis to demonstrate the functional mechanisms associated with dysregulated 
genes between samples from 14.5 to 16.5dpc are highlighted in GO and KEGG pathways that are 









      
# of 
SDEG 
# of SDEG 




Up in WT16.5 vs. WT 14.5 2421 1675 
Down in WT16.5 vs. WT 14.5 1694 134 
HM 
Up in HM16.5 vs. HM 14.5 3153 1936 
Down in HM16.5 vs. HM 14.5 2151 191 




Up in HM 14.5 vs. WT 14.5 8 0 
Down in HM 14.5 vs. WT 14.5 5 0 
 
16.5 
Up in HM 16.5 vs. WT 16.5 30 10 
Down in HM 16.5 vs. WT 16.5 8 3 
 
Table 1: Significantly Differentially Expressed Genes (SDEG, multiple hypothesis testing 
corrected p-value < 0.05) across time and genotype points separately listed for up-/down-









































































































































































































































































































































4.4 Real-Time PCR Confirmation of Dysregulated Genes 
Our qPCR data of selected WT and HM genes (Table 2 and 3) supports RNAseq results 
using normalized fold-change ratio to our reference control genes—18sRNA, GAPDH, and -actin 
(Appendix A).  The qPCR data shown in Figure 10 confirms the results of our RNAseq analysis, 
demonstrating at 16.5dpc WT palates have a significantly increased expression of Cdh1, Ocln and 
F2rl1 and significantly decreased expression of Tnfrsf11b, Fndc3c1, Dlx1, and Gas2 compared to 
the endogenous control set (p<0.01).  Similarly, in HM palates as shown in Figure 11, qPCR data 
confirms RNAseq results showing a significantly increased expression of Chrng, Col2a1, 
Coll11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, Cldn1 and Nrcam and 
significantly decreased expression of Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17, Pdgfc, Twist1, and 























Figure 10. Fold change (log2) expression of WT gene mRNA relative to reference control 
genes (18rSRNA, GAPDH and β-actin). Bar heights indicate mean expression of the genes in 
samples. Error bars indicate 95% confidence interval estimates of the mean expressions. One 
asterisk indicates statistically significant difference between the means of a sample set compared 
to the mean of the control sample set to 5% (correspond to a p-value <0.05); two asterisks indicate 











Figure 11. Fold change (log2) expression of HM gene mRNA relative to reference control 
genes (18rSRNA, GAPDH and β-actin). Bar heights indicate mean expression of the genes in 
samples. Error bars indicate 95% confidence interval estimates of the mean expressions. One 
asterisk indicates statistically significant difference between the means of a sample set compared 
to the mean of the control sample set to 5% (correspond to a p-value <0.05); two asterisks indicate 









CHAPTER 5: DISCUSSION 
Orofacial clefting is the most commonly treated craniofacial anomaly in the pediatric 
hospital setting (Jugessur et al., 2009).  The identification of genetic and environmental causes and 
risk factors continues to be at the forefront of current research.  Scientific advances allowing more 
thorough, sensitive means of gene exploration help identify new mechanisms for embryonic 
development and cleft causation with the ultimate goal of converting scientific findings to clinical 
care (Jugessur et al., 2009).  The development of high-throughput DNA sequencing methods, RNA-
seq, allows the entire transcriptome to be surveyed quantitatively (Wang et al., 2009).  
Bioinformatics analysis was applied to RNA-seq data to identify differentially expressed genes and 
functional pathways that may elucidate the biological mechanisms underlying palate fusion. 
5.1 Known Cleft Palate Genes 
Based on the OMIM and MGI database, current knowledge demonstrates over 300 genes 
that, when mutated, cause CP in mice and humans.  The role of TGF-3 gene has been 
overwhelmingly established as a crucial molecule that is necessary for normal palate 
development—in its absence CP occurs (Ozturk et al., 2013).  In this study we focus on the role of 
Tgf-3 in the murine model and its associated molecules that are fundamental in normal 
palatogenesis.  Our study identifies genes that are functionally regulated by Tgf-3; in WT mice 
normal palatogenesis sustains whereas, in HM mice, CP results due to altered genes under control 
of Tgf-3.  Our data reveals that several significantly differentially expressed genes have been 
previously identified as CP genes. WT mice showed two specific genes (Twist1, Wnt5a) to be 
downregulated significantly at 16.5dpc.  HM mice, on the contrary, showed an increased expression 
of Chrng, Col2a1, Col11a1, Col11a2, and L1cam genes at 16.5dpc, that play crucial roles in 
palatogenesis.  We analyzed the specific cellular function, role in palatogenesis, and association 





Twist acts as a basic helix-loop-helix transcription factor essential for EMT in both 
embryonic development and cancer. Twist is a well-established E-cadherin repressor (Yu et al., 
2008). It has been shown convincingly that EMT is a major mechanism of palatal seam 
disintegration – the critical final stage of palate fusion (Nawshad, 2008).  Twist is present in the 
zone of palatal shelf fusion—indicating its likely importance to palatogenesis.  Further, in 
experiments where Twist expression is downregulated, palate fusion is hindered or delayed (Yu et 
al., 2008).  Conversely, in chicken palates, the addition of Tgf-3 upregulated Twist mRNA 
indicating it is downstream of Tgf- signaling (Sun et al., 1998).  Our data confirms that 
downregulation of Twist gene in HM inhibits palate fusion resulting in a cleft at 16.5dpc.  
Genetic screenings have implicated several isoforms of WNTs—WNT3A, WNT5A, 
WNT11—with non-syndromic CL/P (Meng et al., 2009).  The WNT signaling pathways are 
essential for cell proliferation, differentiation, and survival (Brugmann et al., 2007).  Furthermore, 
these genes are known to regulate mid-face development, upper lip fusion and are likely associated 
with the etiology of orofacial clefts (Brugmann et al., 2007).  In situ hybridization studies have 
shown Wnt5A expression in the frontonasal prominences and maxillary process which fuse to form 
the primary palate (Yamaguchi et al., 1999).  Gene interaction studies suggest a variation in 
WNT5A regulating neural crest cell differentiation may predispose to an orofacial cleft (Chiquet 
et al., 2008).  Specifically, Wnt5a directs cell migration in a graded manner along the 
anteroposterior axis of the palate; loss of Wnt5a in mice leads to a complete cleft of the secondary 
palate (He et al., 2008).  Overall, substantial data demonstrates an essential role of WNT family 
members in orofacial growth allowing immaculate fusion of facial primordia. The HM palate 
showed a decreased expression of Wnt5a from 14.5dpc to 16.5dpc showing a lack of directional 
palatal cell migration and proliferation necessary for both mesenchymal and epithelial homeostasis 





CHRNG (Cholinergic receptor, nicotinic, ) is a transmembrane receptor for acetylcholine 
with five different subunits—two , one , one,  and one .  Binding of acetylcholine activates 
voltage-gated sodium channels resulting in an action potential in muscle (Hoffmann et al., 2006).  
During fetal development, the  subunit is commonly expressed (Kariminejad et al., 2016).  The  
subunit is essential for neuromuscular signal transduction connecting axon and muscle; -knockout 
is lethal in mice (Hoffmann et al., 2006).  In humans, mutations in CHRNG cause Escobar 
syndrome and a spectrum of Multiple Pterygium syndromes characterized by several craniofacial 
deformities including, but not limited to, cleft palate, joint contractures, pterygia and micrognathia 
(Vogt et al., 2012).  Current literature shows pterygium is also associated with IRF6 and p63 
mutations in humans, which are both known to be associated with TGF-3 pathway (Lihua et al, 
2015)  (Ozturk et al., 2013).  Chrng is upregulated in the HM mice at 16.5dpc indicating that in 
absence of Tgf-3 in HM, Irf6 and p63 proteins are differentially expressed resulting in the 
persistence of palatal periderm resulting in palatal cleft. 
Several types of collagen are variably expressed in the developing palate and essential for 
ECM metabolism.  Collagen fibers have been shown to contribute to palatal shelf elevation, shelf 
adhesion, and ECM formation.  COL2A1 mutations are present in Stickler Syndrome and 
chondrodysplasias (Vandenberg et al., 1991, Ahmad et al., 1995).  Further, defects in several 
collagens—Col1a2, Col2a1, Col11a22, and ColXIa1—are linked to cleft palate (Meng et al., 2009, 
Schutte & Murray, 1999).  In the HM palate, Col2a1, Col11a1, and Col11a2 were all significantly 
upregulated from 14.5 to 16.5dpc suggesting their increased presence in the basement membranes 
of persistent, intact palatal epithelia and periderm.  Persistence of palatal periderm ultimately 
impedes palatal fusion resulting in palatal cleft. 
The L1 cell adhesion molecule (L1CAM) is a member of the immunoglobulin gene 
superfamily and is associated with a spectrum of disorders collectively known as L1 syndrome.  X-





carcinomas are some of the variable presentations of L1 malfunction (Schäfer & Altevogt, 2010).  
Abnormalities of L1CAM are characterized by severe mental retardation, hydrocephalus, spastic 
tetraplegia, bilateral adducted thumbs, and orofacial clefts.  Previous literature reports have shown 
individuals with XLH who have cleft palate suggesting that L1CAM may contribute to both 
phenotypes (Okamoto et al., 2004).  While the mechanisms underlying L1cam function are still 
elusive, it is generally involved in cell proliferation, adhesion and migration as well as critical in 
the development of carcinomas. Based on these data, we propose that L1cam in HM is involved in 
maintaining palatal epithelia and periderm attachment and integrity which results in cleft palate. 
5.2 Genes Upregulated at 16.5dpc vs. 14.5dpc in Homozygous Palates  
The TGF- family members are integral to palatogenesis and responsible for an array of 
functions required for palate fusion—cell migration, EMT, ECM synthesis and deposition, 
degradation of basement membrane, cell proliferation and apoptosis.  In HM mice, Tgf-1 and Tgf-
2 are expressed in MEE cells and mesenchymal cells respectively (Nawshad et al., 2004). Several 
upregulated genes in HM mice are under control of other TGF isoforms: Adam12, Clu, Fas, 
Hspg2, Cldn1, Lox, Itgb4, and Klf5.  These genes, regulated by Tgf-1,2 in HM may regulate 
multiple cellular functions essential to proper palatal growth in HM but are unrelated to palatal 
fusion, which is a unique characteristic of cleft palate in Tgf-3 knockouts. 
Disintegrin metalloproteases, ADAMs, regulate key cellular processes such as apoptosis, 
proliferation, and cell adhesion.  ADAMs family members have been shown to be under the control 
of TGF- signaling showing changes in regulation at the gene expression level (Ramdas et al., 
2013).  In the developing HM mouse palate, Tgf-1 and Tgf-2 are expressed in both palatal 
epithelia and mesenchyme (Nawshad et al., 2004).  The upregulation of Adam12 in the HM palate 
at 16.5dpc is indicative of its control by different isoforms of Tgf- necessary for the attainment of 





Clusterin (Clu) is a multifunctional glycoprotein that has a role in epithelial cell 
differentiation, cell-cell adhesion, and regulation of apoptosis (Itahana et al., 2007).  Clu is 
synthesized by cells of epithelial and mesenchymal origin; synthesis is upregulated in tissues 
undergoing remodeling or injury exerting a protective function in a stressed environment.  Tgf-1 
was shown to increase expression of Clu in various cell types: nervous tissue, astrocytes, 
fibroblasts, lung epithelial cells, aortic endothelial cells and in HeLa cells in culture (Wegrowski et 
al., 1999).  The upregulation of Clu at 16.5dpc in HM palatal tissue is a result of induced expression 
by isoform TGF-1 suggesting Clu plays no role in palatal fusion resulting in cleft palate. 
Apoptosis is essential for embryogenesis, particularly in tissue and organ development and 
tissue homeostasis.  Fas is a member of the TNF receptor superfamily and a well-known mediator 
of apoptosis (Goldthorpe et al., 2015).  It has been suggested that Tgf- induces resistance to 
apoptosis in lung fibroblasts through suppression of Fas via miR-29 (Matsushima & Ishiyama, 
2016).  In the HM palate, Fas is upregulated at 16.5dpc induced by other Tgf- isoforms or pro-
apoptotic factors contributing to palatal cell death that is essential in palatogenesis. 
Perlecan (Hspg2) is a proteoglycan that is a key component of basement membranes and 
ECM.  An absence of Hspg2 in mice and humans causes lethal chondrodysplasia (Hara et al., 2017).  
Hspg2 has a roles in cell adhesion, proliferation, and angiogenesis.  Tgf-1-induced Hspg2 
deposition has been demonstrated in COPD airway smooth muscle (Ichimaru et al., 2012). We 
propose that Hspg2 is functional in palatal mesenchyme under the control of Tgf-1 regulating 
palatal mesenchymal ECM necessary for palatal growth in HM mice, but without any implication 
in palatal fusion. 
Claudin-1 (Cldn1), a transmembrane protein localized to the surface of epithelial cells, is 
crucial for formation and function of tight junctions (Zhang et al., 2016).  Disruption of tight 





cell contacts (Katayama et al., 2017).  It has also been demonstrated that Tgf-1 exposure leads to 
EMT and decreased Cldn1 in MDCKII cells (Medici et al., 2006).  We suggest in the HM mouse 
palate, the increased Cldn1 expression from 14.5 to 16.5dpc indicates a persistence of cell-cell 
adhesion and therefore a persistence of the MEE and periderm ultimately hindering palate fusion.  
Lysyl oxidase (Lox) is an enzyme essential for basement membrane development and 
maturation.  Active Lox modifies collagen formation to help stabilize a functional ECM; in excess, 
Lox can lead to compromised basement mebrane function promoting abnormal ECM accumulation 
and fibrotic diseases.  Lox has also been shown to promote apoptosis and act as a tumor suppressor 
(Kim et al., 2017).  In lung cancer, TGF- is shown to increase LOX contributing to cancer 
metastasis (Araz et al., 2014).  In the HM palate, Lox may be upregulated as a result of Tgf-1 and 
Tgf-2 maintaining ECM homeostasis necessary for palatal growth with no role in palate fusion 
seen in WT mice. 
Integrin 4 (Itgb4) is a member of the integrin family of cell adhesion receptors essential 
for cell migration in embryonic development, wound healing, inflammatory responses, and tumor 
metastasis.  Expressed in epithelial cells, Itgb4 is a component of hemidesmosomes that provides 
attachment to the basement membrane (Miyazaki et al., 2015).  Tgf-1 is known to regulate 
expression of several integrins.  The addition of Tgf-1 to various cell types resulted in cytoskeletal 
reorganization of the 4 integrin subunit (Scardigli et al., 1996) suggesting the upregulation of 
Itgb4 in the HM palate is under control of Tgf-1; this upregulation is important for palatal growth 
and elevation by modulating basement membrane with palatal epithelia.  Further, Itgb4 seems to 
have to no role in palate fusion which is strictly regulated by Tgf-3 in WT palates. 
Transcription factor Klf5 belongs to the zinc-finger protein family and acts downstream of 
multiple signaling pathways including TGF-.  Klf5 is a known modulator of proliferation, 





cardiovascular disease (Li et al., 2015).  In HM palatal epithelia, Klf5 is independent of regulatory 
Tgf-3, however it continues to be regulated by both Tgf-1 and Tgf-2 showing its increased 
presence at 16.5dpc.  Such upregulation of Klf5 gene in palatal epithelia in HM mice indicates 
palatal epithelial growth, but no relationship with fusion. 
5.3 Genes Downregulated at 16.5dpc vs. 14.5dpc in Homozygous Palates 
As previously mentioned, Wnt family members are critical to orofacial development.  
Further, Wnt signaling pathways regulate a variety of developmental processes, including cell 
proliferation, differentiation and cell polarity that are fundamental in palate development (Cadigan 
& Nusse, 1997, Wodarz & Nusse, 1998).  Both Wnt3 and Wnt9b are expressed in the developing 
facial ectoderm and the canonical Wnt signaling pathway is activated during facial outgrowth and 
fusion (Lan et al., 2006).  Thus, in mice, reduced Wnt9b expression or lack of Wnt signaling 
pathways, as seen in HM embryos, contributes to failure in palatal morphogenesis resulting in 
palatal cleft. 
Alx4 is a paired-like homeodomain transcription factor that is mainly expressed in the 
mesenchymal tissues of developing bone, teeth, limbs and mammary tissue.  It plays a pivotal role 
in craniofacial development and epithelial-mesenchymal interaction.  Several studies have revealed 
mutations of Alx4 cause craniofacial anomalies, including facial clefting (Beverdam et al., 2001).  
During the development of the palate, as the palatal shelves adhere at the midline, two layers of 
intervening MEE cells form the MES which must be subsequently dissolved to allow successful 
palate fusion.  EMT is thought to be an important mechanism required for MES disintegration 
(Nawshad, 2008).  Deletion of Alx4 was demonstrated to induce reversion of EMT (Yuan et al., 
2015, Hudson et al., 1998).  Therefore, loss of Alx4 in HM palates may impair EMT during palatal 





Pax1 is a member of the paired box (PAX) family of transcription factors.  Members of 
PAX family play critical roles in pattern formation during embryogenesis and may be essential for 
development of the vertebral column (Sonnesen et al., 2008).  High DNA methylation rates of Pax1 
are detected in tissues of several types of cancers, suggesting that Pax1 acts as a tumor suppressor 
gene (Guerrero-Preston et al., 2014).  Inactivation of Pax1 gene may result in enhanced resistance 
to apoptosis and repression of terminal differentiation (Su et al., 2009, Kan et al., 2014, Cheng et 
al., 2016, Hassan et al., 2017).  In our RNA-seq data, downregulated expression of Pax1 in HM 
palates may be responsible for persistence of periderm cells which bolsters the persistence of the 
MES and ultimately leads to failure of fusion in palatal development.  
Kcp is a secreted cysteine-rich domain protein and acts as a regulator of the TGF-β 
superfamily pathways which enhances BMP signaling while inhibiting both the activin-A and TGF-
1-mediated signaling pathways (Soofi et al., 2017).  BMP signaling is essential during organ 
development, including palatogenesis. Specifically, BMP2, BMP4, and BMP5 are expressed in 
both epithelia and mesenchyme throughout palatogenesis (Nie et al., 2006).  Lu et al. showed the 
importance of BMP signaling during palatogenesis by demonstrating a decrease expression of 
Bmp2, -4, and -5 in mice exhibiting cleft palate (Lu et al., 2000). In our HM samples, deficiency of 
Kcp may alter the levels of Bmp signaling, leading to aberrant cell proliferation and cell death 
during palatal development, resulting in palatal cleft.   
Msx1, like the Kcp gene, is also known to regulate BMP signaling; BMP signaling has been 
proposed to be downstream of Msx1 during palatal development (Zhang et al., 2002).  Msx1, a 
member of the Muscle Segment Homeobox gene family, acts as a transcriptional repressor and 
functions in diverse cell types regulating proliferation, differentiation and angiogenesis (Medio et 
al., 2012).  Msx1 is primarily expressed in the growing edges of maxillary prominences and the 
anterior part of the palatal shelves as palatogenesis enters later stages (Hilliard et al., 2005, Zhang 





critical role of Msx1 in palate development (Satokata & Maas, 1994).  As shown in our HM mice, 
reduced expression of Msx1 at 16.5dpc is indicative of cleft palate. 
Ppp1r17 is a substrate for cGMP-dependent protein kinase and is involved in central 
nervous system development and intracellular signal transduction.  Ppp1r17 implements protein 
serine/threonine phosphatase inhibitor activity and inhibits phosphatase activities of protein 
phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) complexes (Endo et al., 1999).  During 
embryonic development, cellular and molecular activities are regulated by phosphorylation and 
dephosphorylation by protein kinases and phosphatases, respectively.  Palatogenesis relies on a 
multitude of orchestrated signal transduction pathways, such as TGF-, requiring protein 
phosphorylation and enzymatic dephosphorylation.  In embryonic murine palates, Pp1 and Pp2a 
were reported to account for virtually all detectable serine/threonine protein phosphatase activity 
during palatogenesis (Weston et al., 2002).  Therefore, decreased expression of Pp1 or Pp2a due 
to impaired function of Ppp1r17 may cause disruption in orchestration of Tgf- signaling pathways 
and ultimately cell proliferation, epithelial differentiation, and apoptosis in palatal development of 
HM mice.  As demonstrated in the HM mouse at 16.5dpc, decreased Ppp1r17 and resulting 
dysfunction of Tgf- pathways results in cleft palate. 
Pdgfc is a member of the platelet-derived growth factor (PDGF) family and plays an 
essential role in the regulation of multiple biological processes including embryonic development, 
cell proliferation, cell migration and survival.  The role of Pdgfc as a mitogenic factor in regulating 
proliferation of mouse embryonic palatal mesenchymal cells has been well established (Ding et al., 
2004, Han et al., 2006). Pdgfc deficiency induces retardation of mesenchymal proliferation and 
differentiation in palatal shelves, which accounts for failure of palate fusion and cleft formation in 
Pdgfc (−/−) embryos (Ding et al., 2004).  Although retardation of palatal growth in Tgf-3 knockout 





to the reduction of Pdgfc.  As seen in the HM mouse at 16.5dpc, a decrease in Pdgfc could 
potentially result in inadequate EMT—a fundamental process in successful palate fusion. 
5.4 Genes Upregulated at 16.5dpc vs. 14.5dpc in Wild-type Palates 
In WT palates, several genes under the control of Tgf-3 are significantly differentially 
expressed compared to HM; consequent lack of these temporal gene changes in HM results in 
palatal cleft.  It is important to reiterate that all isoforms of TGF- ligand (1, 2 and 3) are crucial 
for normal palate development.  These isoforms act in tandem in a well-orchestrated time and 
location dependent manner.  Although mutants of these isoforms result in CP phenotype with 
differing degrees of penetrance (Tgf-1 is embryonically lethal, 20% for Tgf-2); it is Tgf-3 that 
causes 100% penetrance with CP as the only phenotype (Zhu et al., 2012b). However, the 
compromise of cellular and morphological functions of these isoforms vary significantly. Our data 
reveals that upregulated WT genes—Cdh1, Ocln, Lyn, F2rl1, Tspan2, and Tnfrsf11B—may 
contribute to normal palate fusion. 
The cell-cell adhesion protein E-cadherin (Cdh1) is a member of the cadherin family of 
calcium-dependent cell adhesion glycoproteins (Becker et al., 1994).  Just like all epithelia, the 
palatal shelf epithelium expresses Cdh1 during palatogenesis.  Mutation of the Cdh1 gene has been 
shown to cause CL/P (Meng et al., 2009).  In WT mice Cdh1 is upregulated from 14.5 to 16.5dpc.  
At 14.5dpc Cdh1 is essential for integrity of MEE and overlying periderm of the palatal shelves.  
As the palate fuses we expect dissolution of MEE and periderm with a localized decrease in 
epithelial cells and therefore Cdh1 (Nawshad et al., 2007).  However, at 16.5dpc we expect a 
significant increase of stratified squamous epithelial cells lining the oral and nasal sides of the 
palate resulting in an overall increase in Cdh1.   
Similar to Cdh1, the transmembrane protein Occludin (Ocln) plays a role in tight junction 





2016b).  Ocln is essential for homeostasis of epithelia; any decrease in Ocln decreases cell-cell 
adhesion and reduces apoptosis (Mir et al., 2016a).  With the increase in quantity of epithelial cells 
in WT palates, we also expect an increase in occludin.  Both of these genes, Cdh1 and Ocln, enforce 
palatal epithelial adhesion as well as maintain epithelial architectural and functional integrity—
hence their increase in WT is expected and justified. 
The lyn gene belongs to the protein kinase superfamily and is localized to the cell surface 
(Roberts et al., 2014).  Lyn plays an important role in immune response, hematopoiesis, response 
to growth factors and cytokines, and integrin signaling (Lim et al., 2015).  Studies show that Tgf- 
is involved in phosphorylation of Lyn and specifically have shown a link between Lyn and Tgf- in 
chronic myeloid leukemia (CML) (Li et al., 2013).  Using MYL cells from a CML patient, it was 
found that TGF drives LYN ubiquitination and turnover via c-cbl transcription and expression 
(Smith et al., 2012).  Similarly, Tgf- control may be contributing to the increased presence of Lyn 
in WT palates at 16.5dpc to facilitate integrin signaling as well as maintaining normal palatal 
immune response and homeostasis. 
F2R like trypsin receptor 1 (F2rl1), also known as Par2, is a member of the G-protein 
coupled receptor family of proteins serving pleiotropic functions in vertebrate development and 
postnatal homeostasis  (Sales et al., 2015).   Par2 is expressed in various cell types including 
gastrointestinal tract, skin, lung, kidneys, smooth muscle, endothelium, epithelium and fibroblasts.  
Par2 has been found to induce colonic inflammation, kidney inflammation, and tissue fibrosis 
(Chung et al., 2013).  G-protein coupled receptors are known to transactivate EGFR in various cell 
types.  An in vitro study showed Par2 transactivates EGF and TGF--receptors via PI3K and 
MAPKs ultimately leading to phosphorylation of Smad2 and -3.  Smad2/3 phosphorylation is 
essential to TGF--dependent signaling and activation of transcription factors to facilitate palatal 





pathways and proteins, such as G-protein coupled receptors, play a critical role in palate 
development as demonstrated by its increase in WT palates at 16.5dpc (Cobourne, 2004).   
Tetraspanins (Tspans) consist of a large family of 4-transmembrane domain proteins.  
Tspans have recently gained importance as regulators in cancer malignancy, immune response, 
fertilization, and infectious disease (Zhao et al., 2017).  Tspans have been shown to play crucial 
roles in biologic processes including cell adhesion, proliferation, differentiation, and migration 
(Zhao et al., 2017) .  Recently Tspan2 has been found to be the only Tspan family gene induced by 
TGF- in vascular smooth muscle cells via class SMAD pathway (Zhao, Wu et al. 2017).  While 
there is no direct link of Tspan2 to palatogenesis, its implication with TGF-/SMAD pathway and 
crucial role in cell adhesion, proliferation, and differentiation warrant further investigation into its 
role in palatogenesis.  However, our data suggest that the role of Tspan2 may be limited to cellular 
migration, proliferation and different ion via Smad pathways during palatogenesis. 
Osteoprotegrin (Tnfrs11b) is a key regulator of bone metabolism and is crucial for bone 
homeostasis; Tnfrs11b inhibits osteoclast activity allowing new bone formation by osteoblasts 
(Smane & Pilmane, 2016).  Tnfrs11b knockout mice have severe osteoporosis while overexpression 
leads to osteopetrosis (Zehnder et al., 2006).  As early as 14.5dpc, mesenchymal condensations are 
observed on both sides of the palatal midline which undergo chondrogenesis initially and ultimately 
membranous ossification that give rise to the hard palate (Martinez-Alvarez et al., 2004).  We 
expect Tnfrs11b signaling to be upregulated from 14.5 to 16.5dpc in preparation for osteogenesis. 
5.5 Genes Downregulated at 16.5dpc vs. 14.5dpc in Wild-type Palates 
As previously described, downregulation of WT genes allow normal palate fusion.  Our 






Fndc3c1, a member of a novel gene family, encodes a protein consisting of fibronectin 
module type III and  is a component of ECM proteins functioning in cell adhesion, differentiation, 
migration and embryogenesis (Porcionatto, 2006, Potts & Campbell, 1996).  Although Fndc3c1 is 
mostly expressed in all embryonic germ layers except heart and yolk sac from E7.5-E8.5 (Hou et 
al., 2007).  Further, Fndc3c1 is shown to be expressed in trophoblast stem cells during 
extraembryonic ectoderm differentiation in mice (Pearton et al., 2014). During palate formation, 
ectoderm-derived MEE and periderm are created to form a protective shield against premature 
fusion, but must dislodge prior to shelf adherence to allow a confluent palate (Obholz et al., 2006, 
Nawshad, 2008, Hu et al., 2015b). Therefore, it’s logical to postulate that reduced expression of an 
ectoderm differentiation gene, Fndc3c1, may facilitate elimination of periderm from underlying 
epithelium allowing palate fusion.  
Distal-Less Homeobox 1 (Dlx1) encodes a protein that functions as a transcriptional 
regulator of signaling from several TGF- superfamily members.  All six Dlx family members are 
present in the first pharyngeal arch in both mesenchyme and ectoderm (Jeong et al., 2012).  Mice 
with mutations of both Dlx1 and Dlx2 exhibit cleft palate demonstrating the essential role of Dlx 
family in palatogenesis (Jeong et al., 2012).  At early stages in palate formation, the defect in Dlx 
family genes results in a growth defect of palatal shelves.  Later stages of palatogenesis are also 
affected via Dlx1 and Dlx2 regulation of downstream signaling molecules such as Shh, Fgf10, and 
Bmp4 (Jeong et al., 2012).  Our RNA-seq data show decreased activity of Dlx1 at 16.5dpc in the 
WT palates.  We postulate that the decrease in Dlx1 prior to palatal fusion may allow Tgf- 
signaling to properly guide dislodgment of periderm and subsequent fusion in palatogenesis. 
Growth arrest specific gene 2 (Gas2) is a caspase-3 substrate that regulates cell cycle and 
apoptosis (Sgorbissa, Benetti et al. 1999). The cleaved form of Gas2 is capable of modifying 
microfilament and cell shape during apoptosis (Brancolini et al., 1995).  Cell death by apoptosis is 





organisms.  During palatogenesis, MEE cells in the MES are proposed to, in part, undergo apoptosis 
to facilitate mesenchymal confluence (Nawshad, 2008). In vitro, however, cultured murine 
keratinocyte cells displayed reduced Gas2 protein levels during growth arrest induced by TGF- 
treatment, whereas significantly upregulated Gas2 activity was observed in rapidly proliferating 
cells (Manzow et al., 1996). Therefore, it is plausible to suggest that during palate fusion, lower 
levels of Gas2 is a reflection of quiescent epithelial cells undergoing apoptosis or EMT instead of 
robust proliferation. Future studies are necessary to investigate the role of Tgf- in regulating 
expression of Gas2. 
The Bnc2 gene encodes a conserved zinc finger protein containing three pairs of zinc 
fingers and a nuclear localization signal (Vanhoutteghem et al., 2009).  According to reports, Bnc2 
plays a role in skin color saturation and skin cancer development (Jacobs et al., 2015).  Bnc2 is 
found mainly in keratinocytes of stratified squamous epithelium and is functionally involved in cell 
proliferation (Vanhoutteghem et al., 2009).  Observations of growth arrest of tumor cells induced 
by stable expression of Bnc2 also supports Bnc2 as a putative tumor suppressor gene (Akagi et al., 
2009).  In a recent study, Bnc2 was shown in mesenchymal cells surrounding the palatal cleft in 
mice; while the exact role of Bnc2 is unclear, it likely regulates expression of genes that encode 
transcription factors, genes essential for growth, and signaling molecules and receptors necessary 
for successful palate fusion (Vanhoutteghem et al., 2009).  The involvement of Bnc2 in 
palatogenesis warrants further investigation. 
Versican (Vcan) is a chondroitin sulfate proteoglycan and component of the extracellular 
matrix essential to embryogenesis; lack of Vcan is lethal in mice (Snyder et al., 2015).  Vcan plays 
a crucial role in various cellular processes including cell adhesion, proliferation, differentiation and 
apoptosis; one isoform, V1, specifically promotes EMT (Snyder et al., 2015).  Further, increasing 
evidence has demonstrated that V1 is capable of inducing apoptotic resistance in cultured cells 





of the MES is a critical event for successful palate fusion (Iordanskaia & Nawshad, 2011, Nawshad 
et al., 2004, Kaartinen et al., 1997). Thus, it’s plausible that suppressed expression of Vcan at 
16.5dpc allows the breakdown of the MES.  While we know it is a critical gene, further examination 
of Vcan activity throughout embryogenesis would be of benefit to our understanding as to how it 
contributes to palatogenesis.  
5.6 Dysregulated Genes independent of TGF-  
The heat shock protein Crystallin-B (Cryab) is a member of the heat shock protein family 
with an array of biological functions (Malin et al., 2016).  Cryab is known to bind and stabilize 
cytoskeletal proteins and play a role in EMT in liver and lung fibrosis (Malin et al., 2016).    An in 
vitro experiment in retinal pigment epithelial cells showed overexpression of Cryab siRNA 
decreased E-cadherin and increased Snail and Slug in protein and mRNA levels (Ishikawa et al., 
2016).   Snail family members have been implicated in triggering of EMT and cell survival (Kudo-
Saito et al., 2009).  Cryab, in relation to Snail, could be acting as an anti-apoptotic agent in 
persistent palatal shelf epithelium and periderm.  In cleft mice, increased levels of Tgf-1 in the 
palatal mesenchyme induces Snail expression and inhibition of cell death in the MEE (Martinez-
Alvarez et al., 2004).  Upregulated in HM mice at 16.5dpc, the relationship between Cryab and 
Snail may be related to apoptosis of palatal mesenchyme and epithelia that are necessary in 
palatogenesis requiring further investigation.  
Neuronal cell adhesion molecule (Nr-cam) is a member of the immunoglobulin 
superfamily and was recently identified as a target of gene signaling in human melanoma and colon 
carcinoma cells and tissue (Conacci-Sorrell et al., 2005).  Nr-cam protects cells from apoptosis via 
extracellular signal-regulated kinase and AKT signaling pathways (Conacci-Sorrell et al., 2005).  
The PI3K/Akt pathway suppresses apoptosis and promotes cell growth and proliferation (Bian et 





decreased apoptosis in persistent MEE and periderm of palatal shelves ultimately hindering palatal 
fusion. 
5.7 Direct Comparison of Homozygous and Wild-type Palates at 14.5 and 16.5dpc 
The RNA sequencing data shows few differentially expressed genes when directly 
comparing genotypes at 14.5 and 16.5dpc shown in Table 4.   At 14.5, only 13 genes were 
differentially expressed between WT and HM ranging from FC -1.46 to 1.39—a very concentrated 
difference between genotype in comparison to the differential gene expression over time.   
Ephrins are a family of cell surface receptors involved in embryonic development 
including the palate (Risley et al., 2009b).  Ephrins are shown to be necessary for both cell 
proliferation and palatal adhesion; further, multiple ephrin/eph receptors are responsible for normal 
palate development (Risley et al., 2009a).  Mutations in the EphrinB1 gene are seen in 
craniofrontonasal syndrome giving rise to cranial defects including cleft lip and palate in both 
humans and mice (Risley et al., 2009b).  Similarly, EphB2 and EphB3 have been implicated in 
palate development and present in palatal mesenchyme and epithelium (Risley et al., 2009a).  
Knockout of both EphB2 and EphB3 causes cleft palate in mice (Orioli et al., 1996).  Differentially 
expressed Ephb3 signaling directly affects palatogenesis, but the exact role of Ephb3 remains 
undetermined.   
Transcription factor Sox6 belongs to the Sox family and is expressed in various tissues; it 
serves many regulatory functions in the development of mesoderm, ectoderm and endodermal 
tissues.  In the mouse model, Sox6 is expressed in the central nervous system, otic vesicle, somites 
branchial arches, thymus notochord, craniofacial mesenchyme, limb buds, and liver (Hagiwara, 
2011).  Sox6 is implicated in both activation and suppression of gene transcription affecting genes 
essential to palate development and known to contribute to cleft formation such as Fgf3 and Col2a1 





activates Col2a1 (Hagiwara, 2011).  Our current knowledge indicates Sox6 plays various roles in 
embryonic development, warranting further investigation of its involvement in palatogenesis. 
Keratin family proteins comprise the intermediate filament system in epithelial cells having 
significant interactions with the ECM throughout key processes such as development, tissue 
remodeling and repair, and differentiation (Kurpakus et al., 1992).   In the oral cavity, 
immunostaining shows keratin in the oral periderm covering the maxillary processes, palatal 
shelves, and future nasal cavity (Casey et al., 2006).  Periderm has been previously characterized 
by keratin expression (Paul et al., 2017, Iwasaki et al., 2006).   The oral periderm prevents the 
palatal shelves from abhorrently adhering to other oral structures during palatogenesis; further, 
periderm cell death is critical to facilitate palatal shelf adhesion (Casey et al., 2006).  The genotypic 
difference in Krt5 expression, upregulated in HM at 14.5dpc, is likely due to persistent periderm 
and therefore increased expression in the palatal shelf epithelium.  
Greater differences exist between genotypes at 16.5dpc; a total of 38 differentially 
expressed genes existed between WT and HM at 16.5dpc ranging from FC -2.75 to 16.75 as shown 
in Table 5.7.  Epidermal growth factor receptor (Egfr) signaling is essential for normal craniofacial 
development.  Egfr regulates development via downstream targets including matrix 
metalloproteinases (Mmp) (Miettinen et al., 1999).  Studies have shown abnormal function of Egfr 
results in cleft palate (Meng et al., 2009).  In Egfr deficient mice, it is postulated that palate adhesion 
fails due to decreased Mmp presence (Miettinen et al., 1999).  Both Egfr and Mmp13 are 
dysregulated between WT and HM at 16.5dpc; Egfr is upregulated in HM at 16.5dpc while Mmp13 
is downregulated in HM at 16.5dpc.  The difference in expression between HM and WT 
demonstrates the involvement of both Egfr signaling and its target Mmp13 in palatogenesis. 
As previously mentioned, the collagen fibers are known to contribute to palatal shelf 





Col6a6 in HM compared to WT at 16.5dpc is indicative of increased presence of basement 
membranes of persistent, intact palatal epithelia with periderm with a cleft. 
Similar to its counterpart differentially expressed at 14.5, Krt4 is upregulated in HM at 
16.5dpc.  As previously discussed, the increased expression of Krt4 is indicative of persistent 



















Up in HM 14.5 vs. WT 14.5 8 Ephb3, Krt5 




Up in HM 16.5 vs. WT 16.5 30 Egfr, Col6a6, Krt4 




Table 4: Selected genes that are uniquely significantly differentially expressed within genotypes 






5.8 Significantly Dysregulated Gene Ontology Categories & KEGG Pathways 
 Significantly differentially expressed genes were found both inter- and intra- time point 
and genotype.  In order to identify predominant biological processes that are significantly 
dysregulated, genes are grouped by common properties into GO categories, such as cell adhesion 
(Young et al., 2010).  Another method of categorizing genes is by KEGG functional assignment.  
KEGG provides a link from a specific gene to pathway or complex, such as metabolism (Kanehisa 
& Goto, 2000b).   
 Identified functional categories that are uniquely or commonly overrepresented in our 
samples are listed in Figure 4.3c.  In the HM palates, we see significantly upregulated functional 
categories including ECM-receptor interaction, cell adhesion, and focal adhesion.  We expect the 
genes in these categories are likely contributing to the persistence of the periderm layer that 
essentially impedes palate fusion (Nawshad et al., 2004).  Conversely, in WT palates, cell-
differentiation and apoptotic process are significantly overrepresented.  As we expect, proper palate 
fusion requires both cell-differentiation and apoptosis to remove the MES and allow proper fusion 
(Nawshad et al., 2007). 
5.9 Functional Analysis of SDEGs in WT and HM at 16.5 vs. 14.5dpc 
 The RNA-seq data shows that in WT at 16.5dpc of palatal development, several pathways 
are active and functional including: TGF-, ERK/MAPK, p38 MAPK, and PI3K/AKT.  It is known 
that these pathways are under the control of TGF-; however, they can also be regulated by other 
factors active in palate development at 16.5dpc.  These pathways are shown to regulate genes 
displayed in Figure 5.1.  The p38 MAPK pathway is a key mediator downstream of TGF- pathway 
which synergistically causes downregulation of the transcriptional regulator Gsc as demonstrated 
in Figure 5.2.  Gsc is reported to regulate cell migration and EMT during embryonic development 





Tgf-1 conjointly with p38 MAPK and additional molecules shown in Figure 5.3 regulate cell 
morphology and differentiation of fibroblasts that lend to construction of ECM and EMT during 
palate development (Griffith & Hay, 1992, Kalluri & Weinberg, 2009).  
 Conversely in HM, the major pathways illustrate a different regulatory profile at 16.5dpc 
which results in cleft palate as shown in Figure 5.4.  As in the Tgf-3 knockout, Tgf-3 signaling 
is inactive allowing PI3K/AKT and ERK/MAPK pathways to impair normal palate fusion by 
altering the expression of Tlx2 as shown in Figure 5.5.  The Tlx2 gene plays a role in proliferation 
and differentiation of neural crest cell lines (Nelms & Labosky, 2010).  Although the involvement 
of Tlx2 in palatogenesis is largely unexplored, Tlx2 has been reported in diseases associated with 
cleft palate (Puri & Shinkai, 2004).  Genes illustrated in Figure 5.6, such as Tbx3 and Wnt9b, that 
participate in regulating crucial biological processes including cell morphology and embryonic 
morphogenesis show altered expression levels at 16.5dpc in HM and may be responsible for failure 















































































































































Figure 14. SDEGs from 14.5dpc to 16.5dpc in relation to cell morphology and 






























































































































Figure 17. SDEGs from 14.5dpc to 16.5dpc in relation to morphology of 





5.10 Real-time PCR confirmation of Gene Dysregulation 
Our qPCR data is in agreement with our RNA-seq results, shown in Figure 4.4, 
demonstrating at 16.5dpc WT palates have an increased expression of the cell adhesion genes Cdh1, 
Ocln and receptors F2rl1 (Par2) which are essential in palatal MEE cell architecture and play a 
vital role in palatal shelf fusion allowing palatal confluency.  On the contrary, we observe a 
downregulation of Tnfrsf11b, important for osteoclastogenesis, hence, its requirement in palate 
development is negligible (Naranjo et al., 2016).  Similarly, Fndc3c1 is mostly expressed in 
embryonic endoderm, serving little role in palatal embryonic cell origin which are ectoderm and 
ectomesenchymes (Hou et al., 2007).  Although Dlx1 gene is important for craniofacial and palatal 
vertical out growth, its role in palatal fusion as shown in our study has not been reported (Wu et 
al., 2015, Jeong et al., 2012).  Similarly, Gas2, which has been implicated in skeletal development, 
has no implication in embryonic palate development (Diez-Roux et al., 2011).  Accordingly, all 
genes unessential to palate fusion (Tnfrsf11b, Fndc3c1, Dlx1 and Gas2) were shown to be 
downregulated in our study. 
In HM, qPCR data shown in Figure 4.41 confirms RNA-seq results showing an increased 
expression of Chrng, Col2a1, Coll11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, 
Cldn1 and Nr-cam.  First, several genes upregulated in HM palates have been confirmed as known 
CP genes including: Chrng, Col2a1, Col11a1, Col11a2, and L1cam (Vogt et al., 2012, Meng et al., 
2009, Schutte & Murray, 1999, Okamoto et al., 2004, Dixon et al., 2011).  Second, in the Tgf-3 
knockout mouse model, we expect other isoforms, Tgf-1 and Tgf-2 to maintain activity and 
continue control of Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, and Cldn1 as previously discussed 
(Ramdas et al., 2013, Matsushima & Ishiyama, 2016, Ichimaru et al., 2012, Araz et al., 2014, 
Scardigli et al., 1996, Li et al., 2015, Medici et al., 2006).  Finally, independent of Tgf- control, 





normal palate fusion (Nawshad, 2008, Conacci-Sorrell et al., 2005).  We postulate this decreased 
apoptosis lends to cleft formation. 
Genes downregulated at 16.5dpc in HM palates—Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17, 
Pdgfc, Twist1, and Wnt5a—are also in agreement with RNA-seq results.  Downregulation of genes 
essential for embryogenesis, craniofacial development, and orofacial patterning (Wnt9b, Alx4, 
Pax1, Kcp, Msx1, Ppp1r17, and Pdgfc) likely disrupts fundamental processes required for normal 
palate fusion as previously discussed (Cadigan & Nusse, 1997, Beverdam et al., 2001, Sonnesen et 
al., 2008, Soofi et al., 2017, Zhang et al., 2002, Weston et al., 2002, Ding et al., 2004).   
Additionally, we confirm downregulation of known CP genes, Twist1 and Wnt5a, in HM palates 










CHAPTER 6: CONCLUSION 
6.1 Conclusion 
 Our study is the first global gene analysis of Tgf- knockout mice alleles using deep 
sequencing methods. While we know Tgf-3 is essential for proper palate fusion, we do not know 
what downstream molecular mechanisms are altered in Tgf-3 knockouts.  In this study, we 
identified a multitude of significantly differentially expressed genes both temporally and between 
phenotypes that may play key regulatory roles during critical stages of palate development.  The 
genes implicated in CP may lead to a better understanding of the underlying genetic mechanisms 
of palatogenesis and provide novel potential targets for gene therapy approaches in treating cleft 
palate.   
6.2 Future Research and Study Limitations 
 Global transcriptome profiling provides a multitude of genetic information.  We have 
provided various genes that warrant further investigation on their involvement in palatogenesis. 
Continued exploration of genes dysregulated in Tgf- alleles will further contribute to our 
knowledge of downstream molecular activities and pathways controlled by Tgf-, ultimately 
enhancing our understanding of CP deformity and providing new genetic targets for prevention and 
treatment.   
 First, limitations of this study include several difficulties with a murine model.  Research 
animals are expensive and do not predictively reproduce.  This specific strain also experienced a 
virus during the time of the study in which all breeding was halted.  Further, the tissues from mouse 
embryo palates are very small, difficult to extract, and provide very few cells.  Second, this study 
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GOI Cq Ref 
∆ Cq 
Ref E∆ Cqref 
E∆ Cq GOI/ 
E∆ Cqref 
18s rRNA  34 8 110.2 18 1 1.94 56.8 
Gapdh 26 7 109.1 16 1 1.99 54.77 
Actb 28 7 107.6 17 1 1.95 54.87 
Twist1 31 8 112.5 19 1 1.9 59.21 
Wnt5a 25 9 110.5 21 1 1.92 57.55 
Chrng 26 8 106.9 20 1 1.89 56.56 
Col2a1 30 8 108.3 22 1 1.91 56.7 
Col11a1 29 6 109.8 17 1 1.97 55.73 
Col11a2 27 9 110.4 16 1 1.96 56.32 
L1cam 28 8 106.6 18 1 1.9 56.1 
Adam12 26 6 109.5 21 1 1.94 56.44 
Fas 27 7 106.5 20 1 1.91 55.75 
Hspg2 29 7 108.9 21 1 1.99 54.72 
Lox 28 7 107.3 19 1 1.96 54.74 
Itgb4 31 9 106.2 16 1 1.9 55.89 
Klf5 32 8 110.1 17 1 1.92 57.34 
Wnt9b 30 9 109.6 18 1 1.98 55.35 
Alx4 27 7 107.5 19 1 1.93 55.69 
Pax1 28 7 111.5 22 1 1.99 56.03 
Kcp 27 8 109.9 21 1 1.98 55.5 
Msx1 25 9 106.3 20 1 1.9 55.94 
Ppp1r17 24 6 109.2 16 1 1.93 56.58 
Pdgfc 29 8 111.1 18 1 1.99 55.82 
Cdh1 31 7 107.6 19 1 1.92 56.04 
Ocln 32 8 109.5 20 1 1.97 55.58 
F2rl1 27 9 108.5 21 1 1.95 55.64 





Fndc3c1 26 8 106.3 17 1 1.91 55.65 
Dlx1 27 7 111.2 21 1 1.99 55.87 
Gas2 31 7 109.7 19 1 1.96 55.96 
Cldn1 26 6 106.6 20 1 1.89 56.4 
Nrcam 28 9 109.5 21 1 1.92 57.03 
 
